Nuvasive Inc (NUVA) 62.52 $NUVA Strength seen in

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nuvasive Inc (NUVA) 62.52 $NUVA

Strength seen in Haemonetics (HAE): Stock Soars 10.5%
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:30AM CDT
Haemonetics Corporation (HAE) shares rose over 11% in the last trading session.
HAE: 34.38 (+0.86), NUVA: 62.52 (-0.77)

Buy These 5 Profitable Stocks for Improving Your Returns
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:10AM CDT
Net income ratio reveals the bottom line of a company, by reflecting the percentage of net income to total sales revenue.
FB: 122.76 (-1.55), ENTG: 16.78 (-0.19), TPH: 13.26 (-0.25), AHS: 42.67 (-0.64), NUVA: 62.52 (-0.77)

Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors
Marketwire Canada - Mon Aug 01, 6:00AM CDT
SAN DIEGO, CA--(Marketwired - August 01, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O'Halleran and Pat Miles to the Company's Board of Directors effective August 1, 2016. Mr. O'Halleran will serve as an independent director of the Company and member of the Board's Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company's executive management team. Mr. Miles will serve as a non-independent member of the Board.
NUVA: 62.52 (-0.77)

Look for Shares of NuVasive to Potentially Rebound after Yesterday's 1.79% Sell Off
Comtex SmarTrend(R) - Wed Jul 27, 3:21PM CDT
NuVasive (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $59.64 to a high of $62.94. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $61.01 on volume of 999,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NUVA: 62.52 (-0.77)

NuVasive (NUVA) Beats on Q2 Earnings, Raises FY16 View
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:27PM CDT
NuVasive, Inc. (NUVA) reported second-quarter 2016 adjusted earnings per share (EPS) of 40 cents, reflecting a 29% rise from the year-ago quarter.
BSX: 24.18 (-0.25), ZBH: 130.17 (-0.89), GWPH: 94.09 (-2.02), NUVA: 62.52 (-0.77)

Uptrend Call Working As NuVasive Stock Rises 39.5% (NUVA)
Comtex SmarTrend(R) - Wed Jul 27, 12:59PM CDT
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on March 4th, 2016 at $43.48. In approximately 5 months, NuVasive has returned 39.54% as of today's recent price of $60.67.
NUVA: 62.52 (-0.77)

Global Market for Regenerative Medicine & Stem Cells - What's hot, what's not, what's next by 2019?
GlobeNewswire - Wed Jul 27, 8:30AM CDT
The competitive landscape of the global regenerative medicine market includes players such as CONMED Corporation, Anika Therapeutics Inc., Arthrex, Inc., Baxter International Inc., Smith & Nephew PLC, DePuySynthes Inc., Stryker Corporation, Medtronic Inc., and Zimmer Holdings Inc. Though North America and Europe were the largest markets for regenerative medicines, the market players are increasingly shifting their focus on the emerging economies across Asia Pacific such as India, South Korea, Japan, and China. These countries are registering an increased demand for various bone and joint reconstructive products such as Osteocel Plus (NuVasive Inc.), Trinity Evolution (Orthofix Inc.), and INFUSE Bone Graft (Medtronic Inc.) owing to the rapid growth of the healthcare sector and the rising pool of patients. The market players are investing in rigorous research and development initiatives for innovative products.
SNN: 33.44 (+0.26), MDT: 87.55 (-0.51), BAX: 48.42 (-0.08), ANIK: 49.55 (-1.09), NUVA: 62.52 (-0.77), SYK: 115.87 (-1.15)

How These Healthcare Stocks are Performing? -- Antares Pharma, Insulet, Globus Medical, and NuVasive
PR Newswire - Wed Jul 27, 7:20AM CDT
Ahead of today's trading session, Stock-Callers.com shifts focus on the Healthcare sector, which is known for its resiliency during downturns. However, current economic conditions are making it difficult for operators to manage their resources and keep up with the increasing demands. We take a look at this morning's picks and assess their performances at the close on Tuesday, July 26, 2016: Antares Pharma Inc. (NASDAQ: ATRS), Insulet Corp. (NASDAQ: PODD), Globus Medical Inc. (NYSE: GMED), and NuVasive Inc. (NASDAQ: NUVA). Learn more about these stocks by accessing their freenotes at:
PODD: 35.29 (-0.09), GMED: 23.61 (+0.12), NUVA: 62.52 (-0.77), ATRS: 1.01 (-0.02)

NuVasive Reports Second Quarter 2016 Financial Results
Marketwire Canada - Tue Jul 26, 3:02PM CDT
Company Delivers Double-Digit Revenue Growth and Increases Full Year 2016 Guidance
NUVA: 62.52 (-0.77)

Chemed (CHE) Lags Q2 Earnings, Tops Revenues, View Up
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:59AM CDT
Chemed???s (CHE) second-quarter 2016 results were a mixed bag with its bottom-line lagging behind the Zacks Consensus Estimate while revenues exceeded the same
CHE: 145.71 (-1.36), BSX: 24.18 (-0.25), NUVA: 62.52 (-0.77)

Baxter International (BAX) Q2 Earnings, Sales Top; View Up
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 8:25AM CDT
Baxter International Inc (BAX) reported second-quarter 2016 adjusted earnings of 46 cents per share, which surpassed the Zacks Consensus Estimate by 7 cents.
BSX: 24.18 (-0.25), BAX: 48.42 (-0.08), BXLT: 46.02 (-0.18), NUVA: 62.52 (-0.77)

Alere Updates on 10K Filing, Reports Preliminary Q1 Figures
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:24PM CDT
Alere Inc. (ALR) lowered revenue estimate for the year that ended on Dec 31, 2015 and also offered some Q1 figures.
BSX: 24.18 (-0.25), ABT: 45.07 (-0.22), ALR: 36.12 (-0.85), NUVA: 62.52 (-0.77)

Will AmSurg's Merger with Envision Healthcare Drive Growth?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:08PM CDT
AmSurg (AMSG) recently agreed to merge in an all-stock deal with Envision Healthcare to create one of the largest providers of physician services in the U.S.
AMSG: 71.29 (-0.94), BSX: 24.18 (-0.25), EVHC: 23.31 (-0.28), GWPH: 94.09 (-2.02), NUVA: 62.52 (-0.77)

The Zacks Analyst Blog Highlights: NuVasive, Apogee Enterprises, Burlington Stores, Newfield Exploration and Saratoga Investment
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 8:30AM CDT
The Zacks Analyst Blog Highlights: NuVasive, Apogee Enterprises, Burlington Stores, Newfield Exploration and Saratoga Investment
NFX: 41.19 (-0.10), SAR: 16.99 (-0.14), APOG: 46.52 (-0.31), BURL: 73.71 (-2.63), NUVA: 62.52 (-0.77)

Medtronic's IN.PACT Admiral DCB Wins FDA Nod for 150 mm
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 6:22AM CDT
With Medtronic (MDT)being a major player in the medical devices market, surely the FDA approval will accelerate the demand for its peripheral therapy products.
BSX: 24.18 (-0.25), MDT: 87.55 (-0.51), GWPH: 94.09 (-2.02), NUVA: 62.52 (-0.77)

Buy 5 Momentum Picks That Brokers Love
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 3:35PM CDT
When sustainable development is a matter of question, the ideal investment strategy is to go for momentum stocks.
NFX: 41.19 (-0.10), SAR: 16.99 (-0.14), APOG: 46.52 (-0.31), BURL: 73.71 (-2.63), NUVA: 62.52 (-0.77)

Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Thu Jul 14, 3:29AM CDT
NuVasive (NASDAQ:NUVA) was upgraded from Neutral to Overweight at JP Morgan today. The stock closed yesterday at $61.42 on volume of 769,000 shares, above average daily volume of 754,000. NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
NUVA: 62.52 (-0.77)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 181

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 0

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 34

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 207

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 297

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 0

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 86

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 129

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 292

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Carota Unveils Innovative MaaS Service to Transform Mobility

Updated Category News Views 248

Carota Announces Launch of Transformative MaaS Service In a significant move for the transportation sector, Carota has introduced its innovative MaaS (Mobility as a Service) smart mobility service. This decision comes as a response to the rapid changes in global mobility services, highlighting Carota's commitment to adapting and evolving to meet the needs of the modern...

Continue Reading
Fossil Group Sees Growth with Strong Q2 2025 Financials

Updated Category News Views 185

Fossil Group's Financial Performance in Q2 2025 Fossil Group, Inc. (NASDAQ: FOSL) has announced its financial results for the second quarter of 2025, showcasing significant progress amid a fluctuating market landscape. The company recorded worldwide net sales of $220 million, marking a year-over-year decline, yet also presenting an encouraging operating income. Sales...

Continue Reading
Exciting UPCX Global Staking Opportunity with Major Rewards

Updated Category News Views 141

UPCX Limited-Time Staking Event Unveiled UPCX, an innovative blockchain financial services platform, proudly announces an engaging staking opportunity that is designed to foster user participation and spur innovation within its ecosystem. This exciting event invites users to take part in a limited-time stakes initiative, offering a significant reward pool of 4,900 UPC,...

Continue Reading
PepGen Inc. Shareholder Alert: Lawsuit Update and Key Details

Updated Category News Views 187

Update on the PepGen Inc. Class Action Lawsuit Levi & Korsinsky, LLP has taken significant steps to notify investors in PepGen Inc. of a class action securities lawsuit aimed at protecting shareholders' interests. Investors should be aware that the lawsuit concerns allegations of securities fraud that impacted investors during a defined time frame. Understanding the Class...

Continue Reading
Synchronoss Technologies Engages Investors via Upcoming Events

Updated Category News Views 116

Synchronoss Technologies Engages Investors with Upcoming Conferences Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a renowned leader in Personal Cloud platforms, is set to make a significant impact at two investor conferences. The company's President and CEO, Jeff Miller, along with CFO, Louis Ferraro, are ready to share insights...

Continue Reading